Evaluating the Role of Targeted Next-Generation Sequencing in Identifying Mycoplasma pneumoniae and Antimicrobial Resistance Genes in Adult Patients - Takeaways - MDSpire

Evaluating the Role of Targeted Next-Generation Sequencing in Identifying Mycoplasma pneumoniae and Antimicrobial Resistance Genes in Adult Patients

  • By

  • Long Yuan

  • Zhuofan Liu

  • Wenmei Zeng

  • Zie Zhan

  • Bilin Chen

  • Dahai Kang

  • Tai Wan

  • Dongmei Wang

  • Hongmei Zhang

  • Tingyan Dong

  • Yan Rong

  • March 12, 2026

  • 0 min

Share

  • 1

    Mycoplasma pneumoniae is increasingly recognized as a significant cause of community-acquired pneumonia in adolescents and adults.

  • 2

    Timely diagnosis of Mycoplasma pneumoniae infections is crucial to prevent severe complications and improve treatment outcomes.

  • 3

    Targeted next-generation sequencing (tNGS) offers a promising method for rapid and accurate detection of Mycoplasma pneumoniae and antimicrobial resistance.

  • 4

    The study evaluated the clinical utility of tNGS in detecting Mycoplasma pneumoniae among patients with community-acquired pneumonia.

  • 5

    A total of 90 patients with complete clinical data were enrolled in the study to assess the effectiveness of tNGS for Mycoplasma detection.

Original Source(s)

Evaluating the Role of Targeted Next-Generation Sequencing in Identifying Mycoplasma pneumoniae and Antimicrobial Resistance Genes in Adult Patients

  • by Long Yuan, Zhuofan Liu, Wenmei Zeng, Zie Zhan, Bilin Chen, Dahai Kang, Tai Wan, Dongmei Wang, Hongmei Zhang, Tingyan Dong, Yan Rong

  • March 12, 2026

Related Content

Clinical Evaluation and Identification of Human Coronavirus Infections in Children with Acute Respiratory Infections in Xiamen, China, 2022–2024

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.